Related references
Note: Only part of the references are listed.Checkpoint blocking antibodies in cancer immunotherapy
Chrisann Kyi et al.
FEBS LETTERS (2014)
Enhancing Virus-Specific Immunity In Vivo by Combining Therapeutic Vaccination and PD-L1 Blockade in Chronic Hepadnaviral Infection
Jia Liu et al.
PLOS PATHOGENS (2014)
Drug of the year: Programmed Death-1 receptor/Programmed Death-1 Ligand-1 receptor monoclonal antibodies
Caroline Robert et al.
EUROPEAN JOURNAL OF CANCER (2013)
Structure and Interactions of the Human Programmed Cell Death 1 Receptor
Xiaoxiao Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The duck genome and transcriptome provide insight into an avian influenza virus reservoir species
Yinhua Huang et al.
NATURE GENETICS (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection
David Gardiner et al.
PLOS ONE (2013)
B7 family checkpoint regulators in immune regulation and disease
Sabrina Ceeraz et al.
TRENDS IN IMMUNOLOGY (2013)
Programmed Cell Death 1-Directed Immunotherapy for Enhancing T-Cell Function
Koichi Araki et al.
IMMUNITY AND TOLERANCE (2013)
Blockade of bovine PD-1 increases T cell function and inhibits bovine leukemia virus expression in B cells in vitro
Ryoyo Ikebuchi et al.
VETERINARY RESEARCH (2013)
cDNA cloning, genomic structure, molecular characterization and mRNA expression analysis of the Pekin duck interleukin-10 receptor 1
Q. Yao et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
In vivo electroporation improves therapeutic potency of a DNA vaccine targeting hepadnaviral proteins
Ghada Khawaja et al.
VIROLOGY (2012)
Molecular characterization of immunoinhibitory factors PD-1/PD-L1 in chickens infected with Marek's disease virus
Ayumi Matsuyama-Kato et al.
VIROLOGY JOURNAL (2012)
The Expression of PD-1 Ligands and Their Involvement in Regulation of T Cell Functions in Acute and Chronic Woodchuck Hepatitis Virus Infection
Ejuan Zhang et al.
PLOS ONE (2011)
Expression profiling of genes associated with regulatory functions of T-cell subsets in Marek's disease virus-infected chickens
Payvand Parvizi et al.
AVIAN PATHOLOGY (2010)
Features of responding T cells in cancer and chronic infection
Peter S. Kim et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Identification of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) isoforms in the Pekin duck
Qingxia Yao et al.
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY (2010)
The PD-1 pathway in tolerance and autoimmunity
Loise M. Francisco et al.
IMMUNOLOGICAL REVIEWS (2010)
PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells
Kim L. Good-Jacobson et al.
NATURE IMMUNOLOGY (2010)
The development of persistent duck hepatitis B virus infection can be prevented using antiviral therapy combined with DNA or recombinant fowlpoxvirus vaccines
Feng Feng et al.
VACCINE (2010)
Feline programmed death and its ligand: Characterization and changes with feline immunodeficiency virus infection
A. Folkl et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2010)
Cloning and identification of porcine programmed death 1
Jin-Mei Peng et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2010)
Mechanisms of costimulation
Arlene H. Sharpe
IMMUNOLOGICAL REVIEWS (2009)
Ducks: The Trojan Horses of H5N1 influenza
Jeong-Ki Kim et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Soluble PD-1 rescues the proliferative response of simian immunodeficiency virus-specific CD4 and CD8 T cells during chronic infection
Nattawat Onlamoon et al.
IMMUNOLOGY (2008)
DNA vaccination in combination or not with lamivudine treatment breaks humoral immune tolerance and enhances cccDNA clearance in the duck model of chronic hepatitis B virus infection
Alexandre Thermet et al.
JOURNAL OF GENERAL VIROLOGY (2008)
The Common γ-Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Induce the Expression of Programmed Death-1 and Its Ligands
Audrey L. Kinter et al.
JOURNAL OF IMMUNOLOGY (2008)
Interaction of human PD-L1 and B7-1
Manish J. Butte et al.
MOLECULAR IMMUNOLOGY (2008)
The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors
David Yin-Wei Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2
Eszter Lazar-Molnar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Molecular signature of CD8+ T cell exhaustion during chronic viral infection
E. John Wherry et al.
IMMUNITY (2007)
MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0
Koichiro Tamura et al.
MOLECULAR BIOLOGY AND EVOLUTION (2007)
Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses
Manish J. Butte et al.
IMMUNITY (2007)
Porcine PD-L1: cloning, characterization, and implications during xenotransplantation
Dae-Hyun Jeon et al.
XENOTRANSPLANTATION (2007)
Genomics of antiviral defenses in the duck, a natural host of influenza and hepatitis B viruses
M. R. W. MacDonald et al.
CYTOGENETIC AND GENOME RESEARCH (2007)
Restoring function in exhausted CD8 T cells during chronic viral infection
DL Barber et al.
NATURE (2006)
The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling
K Arnold et al.
BIOINFORMATICS (2006)
Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection
WK Foster et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction
SD Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Progress in DNA vaccine for prophylaxis and therapy of hepatitis B
A Thermet et al.
VACCINE (2003)
B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells
SY Tseng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
PD-L2 is a second ligand for PD-I and inhibits T cell activation
Y Latchman et al.
NATURE IMMUNOLOGY (2001)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
GJ Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Immune responses to duck hepatitis B virus infection
AR Jilbert et al.
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY (2000)
Share Paper
